TY - JOUR AU - Poggiali, E. AU - Cassinerio, E. AU - Zanaboni, L. AU - Cappellini, M. D. PY - 2012 DA - 2012// TI - An update on iron chelation therapy JO - Blood Transfus VL - 10 ID - Poggiali2012 ER - TY - JOUR AU - Chalmers, A. W. AU - Shammo, J. M. PY - 2016 DA - 2016// TI - Evaluation of a new tablet formulation of deferasirox to reduce chronic iron overload after long-term blood transfusions JO - Ther Clin Risk Manag VL - 12 ID - Chalmers2016 ER - TY - JOUR AU - Andrews, N. C. PY - 1999 DA - 1999// TI - Disorders of iron metabolism JO - N Engl J Med VL - 341 UR - https://doi.org/10.1056/NEJM199912233412607 DO - 10.1056/NEJM199912233412607 ID - Andrews1999 ER - TY - JOUR AU - Hoffbrand, A. V. AU - Taher, A. AU - Cappellini, M. D. PY - 2012 DA - 2012// TI - How I treat transfusional iron overload JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-05-370098 DO - 10.1182/blood-2012-05-370098 ID - Hoffbrand2012 ER - TY - JOUR AU - Hassell, K. L. PY - 2010 DA - 2010// TI - Population estimates of sickle cell disease in the U.S JO - Am J Prev Med VL - 38 UR - https://doi.org/10.1016/j.amepre.2009.12.022 DO - 10.1016/j.amepre.2009.12.022 ID - Hassell2010 ER - TY - JOUR AU - Sekeres, M. A. PY - 2011 DA - 2011// TI - Epidemiology, natural history, and practice patterns of patients with myelodysplastic syndromes in 2010 JO - J Natl Compr Cancer Netw VL - 9 UR - https://doi.org/10.6004/jnccn.2011.0006 DO - 10.6004/jnccn.2011.0006 ID - Sekeres2011 ER - TY - JOUR AU - Ma, X. PY - 2012 DA - 2012// TI - Epidemiology of myelodysplastic syndromes JO - Am J Med VL - 125 UR - https://doi.org/10.1016/j.amjmed.2012.04.014 DO - 10.1016/j.amjmed.2012.04.014 ID - Ma2012 ER - TY - STD TI - Centers for Disease Control and Prevention. Diseases and Conditions: Thalassemia. https://www.cdc.gov/features/international-thalassemia/. Updated 05 May 2016. Accessed 18 Apr 2017. UR - https://www.cdc.gov/features/international-thalassemia/ ID - ref8 ER - TY - JOUR AU - Wood, J. C. PY - 2008 DA - 2008// TI - Cardiac iron across different transfusion-dependent diseases JO - Blood Rev VL - 22 UR - https://doi.org/10.1016/S0268-960X(08)70004-3 DO - 10.1016/S0268-960X(08)70004-3 ID - Wood2008 ER - TY - JOUR AU - Mitchell, M. AU - Gore, S. D. AU - Zeidan, A. M. PY - 2013 DA - 2013// TI - Iron chelation therapy in myelodysplastic syndromes: where do we stand? JO - Expert Rev Hematol VL - 6 UR - https://doi.org/10.1586/17474086.2013.814456 DO - 10.1586/17474086.2013.814456 ID - Mitchell2013 ER - TY - JOUR AU - Cappellini, M. D. AU - Taher, A. PY - 2009 DA - 2009// TI - Deferasirox (Exjade) for the treatment of iron overload JO - Acta Haematol VL - 122 UR - https://doi.org/10.1159/000243801 DO - 10.1159/000243801 ID - Cappellini2009 ER - TY - JOUR AU - Delforge, M. AU - Selleslag, D. AU - Beguin, Y. AU - Triffet, A. AU - Mineur, P. AU - Theunissen, K. PY - 2014 DA - 2014// TI - Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes JO - Leuk Res VL - 38 UR - https://doi.org/10.1016/j.leukres.2014.02.003 DO - 10.1016/j.leukres.2014.02.003 ID - Delforge2014 ER - TY - STD TI - Porter J, Bowden DK, Economou M, Troncy J, Ganser A, Habr D, et al. Health-related quality of life, treatment satisfaction, adherence and persistence in beta-thalassemia and myelodysplastic syndrome patients with iron overload receiving deferasirox: results from the EPIC clinical trial. Anemia. 2012;2012:297641. ID - ref13 ER - TY - JOUR AU - Payne, K. A. AU - Rofail, D. AU - Baladi, J. F. AU - Viala, M. AU - Abetz, L. AU - Desrosiers, M. P. PY - 2008 DA - 2008// TI - Iron chelation therapy: clinical effectiveness, economic burden and quality of life in patients with iron overload JO - Adv Ther VL - 25 UR - https://doi.org/10.1007/s12325-008-0085-z DO - 10.1007/s12325-008-0085-z ID - Payne2008 ER - TY - JOUR AU - Payne, K. A. AU - Desrosiers, M. P. AU - Caro, J. J. AU - Baladi, J. F. AU - Lordan, N. AU - Proskorovsky, I. PY - 2007 DA - 2007// TI - Clinical and economic burden of infused iron chelation therapy in the United States JO - Transfusion VL - 47 UR - https://doi.org/10.1111/j.1537-2995.2007.01398.x DO - 10.1111/j.1537-2995.2007.01398.x ID - Payne2007 ER - TY - JOUR AU - Kwiatkowski, J. L. PY - 2011 DA - 2011// TI - Real-world use of iron chelators JO - Hematol Am Soc Hematol Educ Prog VL - 2011 ID - Kwiatkowski2011 ER - TY - STD TI - Kwiatkowski JL, Kim HY, Thompson AA. Chelation choices and iron burden among patients with thalassemia in the 21st century: a report from the Thalassemia Clinical Research Network (TCRN) longitudinal cohort [abstract]. Blood. 2009;114:4056. ID - ref17 ER - TY - JOUR AU - Cappellini, M. D. AU - Bejaoui, M. AU - Agaoglu, L. AU - Porter, J. AU - Coates, T. AU - Jeng, M. PY - 2007 DA - 2007// TI - Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemia JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.05.007 DO - 10.1016/j.clinthera.2007.05.007 ID - Cappellini2007 ER - TY - STD TI - Novartis Pharmaceuticals Corporation. Exjade (deferasirox) tablets for oral suspension. Silver Spring, MD: US Department of Health and Human Services; 2013. ID - ref19 ER - TY - JOUR AU - Goldberg, S. L. AU - Giardina, P. J. AU - Chirnomas, D. AU - Esposito, J. AU - Paley, C. AU - Vichinsky, E. PY - 2013 DA - 2013// TI - The palatability and tolerability of deferasirox taken with different beverages or foods JO - Pediatr Blood Cancer VL - 60 UR - https://doi.org/10.1002/pbc.24561 DO - 10.1002/pbc.24561 ID - Goldberg2013 ER - TY - JOUR AU - Rofail, D. AU - Abetz, L. AU - Viala, M. AU - Gait, C. AU - Baladi, J. F. AU - Payne, K. PY - 2009 DA - 2009// TI - Satisfaction and adherence in patients with iron overload receiving iron chelation therapy as assessed by a newly developed patient instrument JO - Value Health VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2008.00390.x DO - 10.1111/j.1524-4733.2008.00390.x ID - Rofail2009 ER - TY - JOUR AU - Elalfy, M. S. AU - Massoud, W. AU - Elsherif, N. H. AU - Labib, J. H. AU - Elalfy, O. M. AU - Elaasar, S. PY - 2012 DA - 2012// TI - A new tool for the assessment of satisfaction with iron chelation therapy (ICT-sat) for patients with beta-thalassemia major JO - Pediatr Blood Cancer VL - 58 UR - https://doi.org/10.1002/pbc.23413 DO - 10.1002/pbc.23413 ID - Elalfy2012 ER - TY - JOUR AU - Barbosa, C. D. AU - Balp, M. M. AU - Kulich, K. AU - Germain, N. AU - Rofail, D. PY - 2012 DA - 2012// TI - A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence JO - Patient Prefer Adh VL - 6 UR - https://doi.org/10.2147/PPA.S24752 DO - 10.2147/PPA.S24752 ID - Barbosa2012 ER - TY - JOUR AU - Kremastinos, D. T. AU - Farmakis, D. PY - 2011 DA - 2011// TI - Iron overload cardiomyopathy in clinical practice JO - Circulation VL - 124 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.050773 DO - 10.1161/CIRCULATIONAHA.111.050773 ID - Kremastinos2011 ER - TY - JOUR AU - Fernández-Real, J. M. AU - Manco, M. PY - 2014 DA - 2014// TI - Effects of iron overload on chronic metabolic diseases JO - Lancet Diab Endocrinol VL - 2 UR - https://doi.org/10.1016/S2213-8587(13)70174-8 DO - 10.1016/S2213-8587(13)70174-8 ID - Fernández-Real2014 ER - TY - STD TI - Smith JA, Harré R, Van Langenhove L. Rethinking methods in psychology. London: Sage Publications; 1995.  ID - ref26 ER - TY - STD TI - Strauss AL, Corbin JM. Basics of qualitative research: techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks, CA: Sage Publications; 1998. ID - ref27 ER - TY - STD TI - Willis GB. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks, CA: Sage Publications; 2005. ID - ref28 ER - TY - JOUR AU - Coons, S. J. AU - Gwaltney, C. J. AU - Hays, R. D. AU - Lundy, J. J. AU - Sloan, J. A. AU - Revicki, D. A. PY - 2009 DA - 2009// TI - Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO good research practices task force report JO - Value Health VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2008.00470.x DO - 10.1111/j.1524-4733.2008.00470.x ID - Coons2009 ER - TY - STD TI - US Department of Health and Human Services, Food and Drug Administration. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009.  ID - ref30 ER - TY - JOUR AU - Rothman, M. AU - Burke, L. AU - Erickson, P. AU - Leidy, N. K. AU - Patrick, D. L. AU - Petrie, C. D. PY - 2009 DA - 2009// TI - Use of existing patient-reported outcome (PRO) instruments and their modification: ISPOR good research practices for evaluating and documenting content validity for the use of existing instruments and their modification PRO task force report JO - Value Health VL - 12 UR - https://doi.org/10.1111/j.1524-4733.2009.00603.x DO - 10.1111/j.1524-4733.2009.00603.x ID - Rothman2009 ER - TY - JOUR AU - Patrick, D. L. AU - Burke, L. B. AU - Gwaltney, C. J. AU - Leidy, N. K. AU - Martin, M. L. AU - Molsen, E. PY - 2011 DA - 2011// TI - Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument JO - Value Health VL - 14 UR - https://doi.org/10.1016/j.jval.2011.06.014 DO - 10.1016/j.jval.2011.06.014 ID - Patrick2011 ER - TY - JOUR AU - Patrick, D. L. AU - Burke, L. B. AU - Gwaltney, C. J. AU - Leidy, N. K. AU - Martin, M. L. AU - Molsen, E. PY - 2011 DA - 2011// TI - Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 2--assessing respondent understanding JO - Value Health VL - 14 UR - https://doi.org/10.1016/j.jval.2011.06.013 DO - 10.1016/j.jval.2011.06.013 ID - Patrick2011 ER - TY - JOUR AU - Walton, M. K. AU - Powers, J. H. AU - Hobart, J. AU - Patrick, D. AU - Marquis, P. AU - Vamvakas, S. PY - 2015 DA - 2015// TI - Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment - emerging good practices for outcomes research task force JO - Value Health VL - 18 UR - https://doi.org/10.1016/j.jval.2015.08.006 DO - 10.1016/j.jval.2015.08.006 ID - Walton2015 ER - TY - JOUR AU - Matza, L. S. AU - Patrick, D. L. AU - Riley, A. W. AU - Alexander, J. J. AU - Rajmil, L. AU - Pleil, A. M. PY - 2013 DA - 2013// TI - Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force JO - Value Health VL - 16 UR - https://doi.org/10.1016/j.jval.2013.04.004 DO - 10.1016/j.jval.2013.04.004 ID - Matza2013 ER - TY - JOUR AU - Yeaw, J. AU - Benner, J. S. AU - Walt, J. G. AU - Sian, S. AU - Smith, D. B. PY - 2009 DA - 2009// TI - Comparing adherence and persistence across 6 chronic medication classes JO - J Manag Care Pharm VL - 15 ID - Yeaw2009 ER - TY - JOUR AU - Delea, T. E. AU - Edelsberg, J. AU - Sofrygin, O. AU - Thomas, S. K. AU - Baladi, J. F. AU - Phatak, P. D. PY - 2007 DA - 2007// TI - Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review JO - Transfusion VL - 47 UR - https://doi.org/10.1111/j.1537-2995.2007.01416.x DO - 10.1111/j.1537-2995.2007.01416.x ID - Delea2007 ER - TY - STD TI - Squires LA, Lombardi DP, Sjostedt P, Thompson CA. A systematic literature review on the assessment of palatability and swallowability in the development of oral dosage forms for pediatric patients. Therap Innov Regul Sci. 2013;47:533–41. ID - ref38 ER - TY - JOUR AU - Alvarez, O. AU - Rodriguez-Cortes, H. AU - Robinson, N. AU - Lewis, N. AU - Pow Sang, C. D. AU - Lopez-Mitnik, G. PY - 2009 DA - 2009// TI - Adherence to deferasirox in children and adolescents with sickle cell disease during 1-year of therapy JO - J Pediatr Hematol Oncol VL - 31 UR - https://doi.org/10.1097/MPH.0b013e3181b53363 DO - 10.1097/MPH.0b013e3181b53363 ID - Alvarez2009 ER - TY - JOUR AU - Guest, G. AU - Bunce, A. AU - Johnson, L. PY - 2006 DA - 2006// TI - How many interviews are enough? An experiment with data saturation and variability JO - Field Methods VL - 18 UR - https://doi.org/10.1177/1525822X05279903 DO - 10.1177/1525822X05279903 ID - Guest2006 ER - TY - JOUR AU - Morse, J. M. PY - 2000 DA - 2000// TI - Determining sample size JO - Qual Health Res VL - 10 UR - https://doi.org/10.1177/104973200129118183 DO - 10.1177/104973200129118183 ID - Morse2000 ER -